Roddick, Alistair J.
Wonnacott, Alexa
Webb, David
Watt, Angela
Watson, Michael A.
Staplin, Natalie
Riding, Alex
Lioudaki, Eirini
Kuverji, Apexa
Kossi, Mohsen El
Holmes, Patrick
Holloway, Matt
Fraser, Donald
Carvalho, Chris
Burton, James O.
Bhandari, Sunil
Herrington, William G.
Frankel, Andrew H.
Article History
Received: 25 April 2023
Accepted: 19 September 2023
First Online: 25 October 2023
Declarations
:
: Not applicable.
: Not applicable.
: SB reports honoraria for lectures, presentations and speaker bureaus from Astra Zeneca. JOB reports a leadership position as chair of the UK Kidney Association Clinical Practice Guidelines Committee and reports honoraria for speaker bureaus from AstraZeneca, Boehringer-Ingelheim and NAPP. CC reports support from North East London Integrated Care Board, Clinical Effectiveness Group, Queen Mary University of London, and National Institute of Health Research, and reports a grant or contract from the NIHR School of Primary Care Research. MEK reports participation on advisory boards for GlaxoSmithKline and Astella. AHF reports an institutional grant from Boehringer-Ingelheim for participation in the EMPA-KIDNEY study, honoraria or personal fees from Boehringer-Ingelheim and AstraZeneca, support for attending meetings from AstraZeneca, and participation in advisory boards for Boehringer-Ingelheim and AstraZeneca. DF reports unpaid leadership roles with the American Society of Nephrology Education Committee, EuroPD management board, and the International Society of Peritoneal Dialysis Programme Committee. MH reports honoraria from AstraZeneca and UK Renal Pharmacy Group. PH reports a personal grant from Roche Diagnostics, honoraria or personal fees from AstraZeneca, NovoNordisk and Boehringer-Ingelheim, and participation in data safety monitoring board or advisory boards for Abbott, AstraZeneca, and Bayer. AJR, WGH and NS report institutional grant funding from Boehringer-Ingelheim and Eli Lilly. NS additionally reports institutional grant funding from NovoNordisk. WGH additionally reports funding from the UK Medical Research Council–Kidney Research UK Professor David Kerr Clinician Scientist Award. AWa reports honoraria and support for travel expenses from GlaxoSmithKline. DW reports honoraria from ABCD and Sanofi Aventis and reports participation in a data safety monitoring board or advisory board for the BARI 2 study. AWo reports honoraria from Bayer and AstraZeneca and participant in advisory board for Bayer. AK, EL, MAW, and AR have no competing interests to declare.